Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,371 | -23,171 | -10,272 | -15,628 | -6,722 |
| Depreciation Amortization | 523 | 344 | 173 | 660 | 502 |
| Accounts receivable | 772 | 789 | 781 | N/A | -5,021 |
| Accounts payable and accrued liabilities | 1,652 | 1,952 | 475 | N/A | -1,826 |
| Other Working Capital | -2,245 | -1,113 | -587 | -15,490 | -20,308 |
| Other Operating Activity | -287 | -1,351 | -529 | 6,846 | 12,082 |
| Operating Cash Flow | $-39,956 | $-22,550 | $-9,959 | $-23,612 | $-21,293 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -750 | -15,130 | -20,562 | N/A | 12,750 |
| PPE Investments | -416 | -382 | -79 | -750 | -437 |
| Other Investing Activity | 0 | 0 | 0 | -2,701 | 0 |
| Investing Cash Flow | $-1,166 | $-15,512 | $-20,641 | $-3,451 | $12,313 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 378 | 163 | 2 | N/A | 121 |
| Other Financing Activity | 0 | 0 | 0 | 227 | 0 |
| Financing Cash Flow | $378 | $163 | $2 | $227 | $121 |
| Exchange Rate Effect | 357 | 299 | 75 | -595 | 388 |
| Beginning Cash Position | 78,232 | 78,232 | 78,232 | 105,663 | 105,663 |
| End Cash Position | 37,845 | 40,632 | 47,709 | 78,232 | 97,192 |
| Net Cash Flow | $-40,387 | $-37,600 | $-30,523 | $-27,431 | $-8,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,956 | -22,550 | -9,959 | -23,612 | -21,293 |
| Capital Expenditure | -418 | -384 | -81 | N/A | -437 |
| Free Cash Flow | -40,374 | -22,934 | -10,040 | -23,612 | -21,730 |